FDA FY 2019 Budget Justification Light On Cosmetics Progam Details
This article was originally published in The Rose Sheet
Executive Summary
There’s no new wealth of information on FDA’s cosmetics activities in its justification for proposed fiscal 2019 spending, potentially signaling that cosmetics will remain a low-priority area for the agency.